| Kayla D Brazelton, DO | |
|
920 Stanton L Young Blvd Ste 3440, Oklahoma City, OK 73104-5036 | |
| (405) 271-5251 | |
| Not Available |
| Full Name | Kayla D Brazelton |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 920 Stanton L Young Blvd Ste 3440, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083241269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 7431 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kayla D Brazelton, DO 920 Stanton L Young Blvd Ste 3449, Oklahoma City, OK 73104-5036 Ph: (405) 271-5251 | Kayla D Brazelton, DO 920 Stanton L Young Blvd Ste 3440, Oklahoma City, OK 73104-5036 Ph: (405) 271-5251 |
News Archive
A group of leading scientists has warned that Britain and Europe collectively could face more than a million deaths in an impending "Antibiotic Armageddon" unless more is spent on developing new cures, rapid diagnostics and preventative measures to combat the spread of drug resistant diseases.
Trimeris, Inc. (NASDAQ:TRMS) today announced financial results for the quarter ended June 30, 2009, reporting net income of $1.3 million, or $0.06 per share compared with $590,000, or $0.03 per share for the quarter ended June 30, 2008. This result was primarily driven by decreased operating expenses offset, in part, by decreased FUZEON® sales and an increase in tax expense.
Highlights from the Lymphoma Research Foundation (LRF) 2009 Mantle Cell Lymphoma Consortium (MCLC) Scientific Workshop will be published in the March 2010 issue of Leukemia & Lymphoma. Traditionally accessible to subscribers for period of one year, Leukemia and Lymphoma has agreed to make this report available to the public for one month - Mantle Cell Lymphoma: Report of the 2009 MCL Consortium Workshop.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the "RNA Silencing: Mechanism, Biology, and Application" Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam's therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington's disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.
› Verified 4 days ago
Lindsay Horn, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1140 N Hudson Ave, Oklahoma City, OK 73103 Phone: 405-858-2800 | |
Adil Tumbi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5251 | |
Matthew Michael Ryan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 800 N W 9th Street, Suite 100, Oklahoma City, OK 73106 Phone: 405-815-5050 Fax: 405-815-5051 | |
Dr. Meheroz H Rabadi, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-456-1000 Fax: 405-456-1504 | |
Willis Holloway Jr., M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 6613 N Meridian Ave, Oklahoma City, OK 73116 Phone: 405-603-8450 Fax: 405-603-8455 | |
Chauncey Atterberry, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-456-1000 | |
Ethan D Lindsey, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1117 Nw 50th St, Oklahoma City, OK 73118 Phone: 405-842-4435 Fax: 405-842-2846 |